
U.S. FDA policy benefits South Korean biotech company
May 9 (UPI) -- A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which is scheduled to retire animal testing. Organoid Science debuted on the Seoul bourse Friday, with its share price …